SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
HJN Sverige AB/Neko Health
1,600 participants
Jul 1, 2024
OBSERVATIONAL
Conditions
Summary
This clinical investigation will evaluate a novel contactless technology for assessing arterial stiffness and pulse wave characteristics and explore its potential in assessment of coronary artery disease, aortic stenosis and heart failure, in a population-based sample aged 58-72 years. It will be the first in clinical setting, pilot stage, observational investigation to evaluate the clinical safety, performance and diagnostic accuracy of Cardio P4, a laser-doppler vibrometry (LDV) and microwave radar-based device.
Eligibility
Inclusion Criteria1
- Subjects already included in the main / general SCAPIS 2 study at Danderyd Hospital in Stockholm, and of which has also participated in the echocardiography examination
Exclusion Criteria1
- Patients unable to provide an informed consent
Interventions
Use of standard equipment for usual care
Physiological data acquisition equipment
GE Vivid E95
Arteriograph, Tensiomed, Hungary
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07001007